Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.

[1]  J. Elder,et al.  Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders. , 2020, Neurologia i neurochirurgia polska.

[2]  M. Nalls,et al.  Comprehensive assessment of PINK1 variants in Parkinson's disease , 2020, Neurobiology of Aging.

[3]  J. Jankovic,et al.  Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. , 2019, Parkinsonism & related disorders.

[4]  L. Pihlstrøm,et al.  Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature , 2019, npj Parkinson's Disease.

[5]  L. Menalled,et al.  The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin , 2019, Biomolecules.

[6]  E. Broussolle,et al.  What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective. , 2019, Parkinsonism & related disorders.

[7]  I. König,et al.  Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review , 2018, Movement disorders : official journal of the Movement Disorder Society.

[8]  Andrew B Singleton,et al.  Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance , 2016, Journal of neurochemistry.

[9]  C Büchel,et al.  Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia , 2007, Neurology.

[10]  G. Schellenberg,et al.  Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients , 2007, Annals of neurology.

[11]  A. Lieberman,et al.  Parkinson's disease: a clinical review. , 1974, The American journal of the medical sciences.